Fingerprint
Dive into the research topics of 'Nivolumab for the treatment of classical Hodgkin lymphoma after failure of autologous stem cell transplant and brentuximab'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Research output: Contribution to journal › Article › peer-review